Fertility startup Inito wants to use AI-designed antibodies to expand at-home health tests
Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
